# Orforglipron (Oral GLP-1 Research Compound)

> Oral, non-peptide GLP-1 receptor agonist in bottles of 30 research capsules

All products are sold strictly for laboratory research use only. Not for human or veterinary use.

- Web page: https://peptidemedixeu.com/en/products/orforglipron/
- Brand: Peptide Medix EU
- Category: [GLP-1 & Incretin Peptides](https://peptidemedixeu.com/en/collections/glp-1-peptides/)
- Purity: HPLC tested for identity and purity; lot-matched COA available
- from €97 (EUR)

## Sizes and prices (EUR)

| Size | Price | SKU |
| --- | --- | --- |
| 3 mg · 30 capsules | €97 | ORFORGLIPRON-3-MG-30-CAPSULES |
| 12 mg · 30 capsules | €165 | ORFORGLIPRON-12-MG-30-CAPSULES |

_Catalog prices at build time; the web page and checkout are authoritative._

## Specifications

- **Form:** Oral capsules in a sealed bottle with desiccant
- **Purity:** HPLC tested for identity and purity; lot-matched COA available
- **Available sizes:** 3 mg × 30 capsules, 12 mg × 30 capsules
- **Compound class:** Non-peptide small-molecule GLP-1 receptor agonist
- **Molecular target:** Glucagon-like peptide-1 receptor (GLP-1R), a class B GPCR
- **Signalling profile:** Biased partial agonism — cAMP/Gs-favoured with reduced β-arrestin recruitment
- **Structural note:** Small organic molecule; no amino acid sequence and no peptide backbone
- **Also known as:** LY3502970, OWL833
- **Delivery note:** Studied as an oral compound without SNAC or other peptide absorption enhancers
- **Research areas:** Incretin receptor pharmacology, glucose-dependent insulin secretion, gastric emptying, food-intake and body-composition models
- **Regulatory status:** Investigational compound; not supplied as an approved medicine
- **Reconstitution:** None required — supplied in finished capsule form
- **Storage:** Room temperature in the sealed bottle, protected from light, heat and humidity

## Description

Orforglipron activates the glucagon-like peptide-1 receptor, yet it is not a peptide — it is a small, drug-like molecule. That fact alone accounts for the research interest: all the heavily studied incretin agents that came before it (tirzepatide, liraglutide, semaglutide) are peptides, and peptides are digested and poorly absorbed, which limits oral use. Orforglipron engages the receptor the way a conventional small-molecule drug would, so it is investigated as an oral compound that needs no absorption enhancer like SNAC.

How it signals is the other reason it appears in comparative studies. Published data characterise it as a biased partial agonist: it favours Gs-driven cAMP production and recruits less beta-arrestin than peptide agonists, and weaker arrestin recruitment goes hand in hand with slower receptor internalisation and desensitisation. Whether that alters the downstream phenotype is exactly what such comparisons aim to find out. In the literature it also appears as LY3502970 and OWL833 — search under both when compiling references. We supply 3 mg and 12 mg capsules, thirty per bottle with a desiccant, stored at room temperature; no cold chain or reconstitution is needed, as you would expect for a small organic molecule rather than a peptide.

## Frequently asked questions

### What kind of compound is orforglipron?

A small, non-peptide molecule that switches on the GLP-1 receptor. Investigated as an oral incretin agonist, it serves in research as the small-molecule comparator to peptide GLP-1 analogues like tirzepatide and semaglutide.

### In what way is it different from oral semaglutide?

Oral semaglutide is a peptide that relies on the absorption enhancer SNAC to get through the gut; orforglipron contains no peptide and is studied as an ordinary oral small molecule. Their receptor signalling also differs — orforglipron is described as a biased partial agonist.

### How is its purity confirmed?

HPLC testing checks identity and purity for every lot, and the lot's Certificate of Analysis can be viewed on this page before ordering. It records the methods used and the results for the specific lot you receive.

### Which strengths are offered?

Bottles of 30 capsules at either 3 mg or 12 mg. Two strengths let labs set up concentration comparisons without weighing bulk powder, and both come in sealed bottles containing a desiccant.

### How should the capsules be kept?

At room temperature in the sealed bottle, away from light, heat and humidity, with the desiccant left in. Don't move capsules into unlabelled containers, and note lot number and opening date to keep the material traceable.

---

All products offered on this website are intended solely for in-vitro laboratory research and development by qualified professionals. They are not drugs, foods, cosmetics or dietary supplements, and are not intended to diagnose, treat, cure or prevent any disease. Products must not be introduced into humans or animals in any manner. By purchasing, you confirm that you are a qualified researcher and accept full responsibility for handling and storage in accordance with applicable laws.

Peptide Medix EU · https://peptidemedixeu.com/en/products/orforglipron/